Ciencias de la vida y de la materia Cardio-oncología

Tratamiento precoz de la disfunción ventricular asintomática

19/06/2015

Descripción
Professor Tom Marwick was appointed Director of the Menzies Research Institute Tasmania in July 2012 and commenced in this position on 15 October 2012. He has a strong interest in research directed at practical health outcomes. He has an outstanding record in both research and research leadership in Australia and internationally. Professor Marwick's specialty is cardiac imaging in heart failure and coronary disease, and the detection of early stages of cardiac dysfunction. His other clinical interests include the cardiac complications of cancer and cancer treatment, valvular heart disease and advanced coronary disease. He is particularly interested in appropriate and cost-effective application of cardiac imaging techniques for treatment selection and monitoring. Before coming to Menzies, Professor Marwick was Section Head, Cardiovascular Imaging, at the Center for Cardiovascular Imaging at the Cleveland Clinic, Ohio, USA. Professor Marwick has a long and distinguished career in cardiovascular health and research since his graduation with honours from the University of Melbourne in 1981 with a degree in Medicine. He completed his PhD in Cardiovascular Imaging at the University of Louvain in Belgium in 1994 and a Masters of Public Health in 2011 at the Harvard School of Public Health in Boston, USA. In 2011 Professor Marwick was invited to give the Kempson Maddox Lecture, the Cardiac Society of Australia and New Zealand's premier annual oration. Other career highlights to date include winning his first program grant from the National Health and Medical Research Foundation in 2009, the culmination of a decade's work in his field, and winning the Foundation's Eccles Award (named after the Australian Nobel Prize-winner Sir John Eccles) in 1999.
"La Fundación Ramón Areces no se hace responsable de las opiniones, comentarios o manifestaciones realizados por las personas que participan en sus actividades."

Descripción

Professor Tom Marwick was appointed Director of the Menzies Research Institute Tasmania in July 2012 and commenced in this position on 15 October 2012. He has a strong interest in research directed at practical health outcomes. He has an outstanding record in both research and research leadership in Australia and internationally. Professor Marwick's specialty is cardiac imaging in heart failure and coronary disease, and the detection of early stages of cardiac dysfunction. His other clinical interests include the cardiac complications of cancer and cancer treatment, valvular heart disease and advanced coronary disease. He is particularly interested in appropriate and cost-effective application of cardiac imaging techniques for treatment selection and monitoring. Before coming to Menzies, Professor Marwick was Section Head, Cardiovascular Imaging, at the Center for Cardiovascular Imaging at the Cleveland Clinic, Ohio, USA. Professor Marwick has a long and distinguished career in cardiovascular health and research since his graduation with honours from the University of Melbourne in 1981 with a degree in Medicine. He completed his PhD in Cardiovascular Imaging at the University of Louvain in Belgium in 1994 and a Masters of Public Health in 2011 at the Harvard School of Public Health in Boston, USA. In 2011 Professor Marwick was invited to give the Kempson Maddox Lecture, the Cardiac Society of Australia and New Zealand's premier annual oration. Other career highlights to date include winning his first program grant from the National Health and Medical Research Foundation in 2009, the culmination of a decade's work in his field, and winning the Foundation's Eccles Award (named after the Australian Nobel Prize-winner Sir John Eccles) in 1999.

"La Fundación Ramón Areces no se hace responsable de las opiniones, comentarios o manifestaciones realizados por las personas que participan en sus actividades."

Vídeos
Ciencias de la vida y de la materia Cardio-oncología

Cardiotoxicidad por quimioterapia. ¿Qué debo saber como paciente?

19/06/2015

¿Cómo puedo prevenir o reducir el riesgo de cardiotoxicidad?

19/06/2015

Recetas en prevención cardiovascular

19/06/2015

Conferencia inaugural: Situación del cáncer en el siglo XXI: retos de las sociedades científicas

19/06/2015

Biología tumoral. Genoma y cáncer

19/06/2015

Cardiotoxicidad inducida por los antiguos y los nuevos agentes antitumorales

19/06/2015

Cardiotoxicidad inducida por radioterapia

19/06/2015

Prevención de cardiotoxicidad: nuevas estrategias en el manejo de los fármacos antitumorales

19/06/2015

Nuevos biomarcadores de riesgo de tromboembolismo en pacientes con cáncer

19/06/2015

Utilidad de los biomarcadores en el diagnóstico precoz y en la estratificación de riesgo cardiaco de pacientes oncológicos

19/06/2015

Isquemia miocárdica en el enfermo oncológico

19/06/2015

Hipertensión arterial secundaria al tratamiento del cáncer

19/06/2015

Lesiones valvulares por radioterapia

19/06/2015

Insuficiencia cardiaca aguda tras tratamiento con quimioterapia

19/06/2015

Fibrilación auricular en el paciente con cáncer

19/06/2015

Prevención de cardiotoxicidad: tratamiento óptimo de los factores de riesgo cardiovascular

19/06/2015

Tratamiento precoz de la disfunción ventricular asintomática

19/06/2015

Protocolos de monitorización de cardiotoxicidad con quimioterapia y radioterapia

19/06/2015